Showing results (161-170 of 293) with videos related to
Sort By:
Pageof 30
Chinese Journal of Cancer|January 24, 2018
Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinomaYan Liu, Xiaojie Tan, Wenbin Liu, et al.International Journal of Radiation Oncology, Biology, Physics|February 14, 2006
Sustained long-term immune responses after in situ gene therapy combined with radiotherapy and hormonal therapy in prostate cancer patientsTetsuo Fujita, Bin S Teh, Terry L Timme, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 5, 2014
Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinicLydia T Madsen, Deborah A Kuban, Seungtaek Choi, et al.Epigenetics|February 19, 2016
Differentially methylated genes and androgen receptor re-expression in small cell prostate carcinomasBrittany Kleb, Marcos R H Estécio, Jiexin Zhang, et al.European Urology Oncology|August 22, 2022
Coffee Intake, Caffeine Metabolism Genotype, and Survival Among Men with Prostate CancerJustin R Gregg, Jeri Kim, Christopher Logothetis, et al.The Journal of Pathology|June 5, 2013
Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progressionGustavo Ayala, Matteo Morello, Anna Frolov, et al.Scientific Reports|May 27, 2016
A genetic polymorphism affects the risk and prognosis of renal cell carcinoma: association with follistatin-like protein 1 expressionYan Liu, Xue Han, Yongwei Yu, et al.Cancer Research|October 26, 2011
GLIPR1 suppresses prostate cancer development through targeted oncoprotein destructionLikun Li, Chengzhen Ren, Guang Yang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
A phase II trial of vorinostat (suberoylanilide hydroxamic acid) in metastatic breast cancer: a California Cancer Consortium studyThehang H Luu, Robert J Morgan, Lucille Leong, et al.European Urology|July 10, 2012
A phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell carcinomaNizar M Tannir, Elizabeth Plimack, Chaan Ng, et al.Pageof 30